Affymetrix has launched SensationPlus FFPE Amplification and 3' IVT Labeling Kit (SensationPlus FFPE Reagent Kit). SensationPlus FFPE Reagent Kit, which comprises RNA amplification and labeling modules, is designed to enable gene ...
Tags: FFPE Reagent Kit, 3'IVT Labeling Kit, clinical technology
Aushon has introduced new Cira multiplex immunoassay platform for protein biomarker analysis. Cira immunoassay includes a circular assay design, microarray printing, a new high-resolution imager with built-in acquisition algorithms and a ...
Tags: Aushon, Cira immunoassay, platform, protein biomarker analysis
National Institutes of Health(NIH),under the SHIFT initiative,has granted two Small Business Innovative Research(SBIR)Phase I awards,totaling$800k over 2 years,to Circulomics. Circulomics will use the grants to develop its Ligo-miR ...
Tags: NIH, SHIFT, SBIR, Ligo miR microRNA assay technology
Aushon is planning to launch its new multiplex protein biomarker platform, which the company says incorporates several engineering breakthroughs to deliver ELISA-level performance. Aushon's microarray printing, novel assay design, ...
SQI Diagnostics has introduced SQiDlite multiplexing system for pharmaceutical drug development and contract research organizations performing bioanalytical and immunogenicity testing. The SqiDlite system, which can run on the company's ...
Tags: SQI Diagnostics, SQiDlite multiplexing system, immunogenicity testing
Agendia, a developer of genomic-based diagnostic products, has unveiled ColoPrint microarray-based 18-gene expression signature. The ColoPrint assay provides critical additional information for treatment decisions for stage II colon ...
Tags: ColoPrint, Agendia, colon cancer patients
Affymetrix and PathGEN Dx have entered into an agreement for the development of an in-vitro diagnostic kit for pathogen detection. Under the agreement, PathGEN Dx will use its PathGEN PathChip for the development of the kit, designed to ...
Tags: in-vitro diagnostic kit, kit for pathogen detection, samples
The National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes of Health has awarded Phase I small business innovation research grant of $600,000 to Antigen Discovery to develop a microfluidic point of care ...
Tags: POC diagnostic device, diagnostic device, serodiagnostic antigens
SIRS-Lab has completed enrolling patients in a clinical study of its VYOO molecular diagnostic test, designed to detect presence of pathogens' genetic material from whole blood. The prospective, blinded multicenter study, which has ...
Tags: VYOO molecular diagnostic test, pathogens'genetic material, VYOO test
The molecular cancer diagnostics company, Agendia, has introduced ColoPrint microarray-based 18-gene expression assay. The ColoPrint assay is designed for predicting the risk of distant recurrence for stage II colon cancer patients who ...
Tags: molecular cancer diagnostics, expression assay, cancer diagnostics